One of the newest marijuana listings on a senior US exchange has started receiving analyst coverage from leading financial institutions.

On Monday (August 26), Cowen (NASDAQ:COWN), BMO Capital Markets and CIBC Capital Markets each launched research coverage of Sundial Growers (NASDAQ:SNDL).


Vivien Azer, managing director and senior research analyst at Cowen, offered the most bullish outlook on the marijuana company. The analyst gave a “buy” rating and assigned a US$20 price target.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Azer is confident that Sundial Growers will be able to deliver results for its craft product at scale.

Shares of the cannabis grower opened on Monday at a price of US$9.54. As of 3:28 p.m. EDT, the company was trading at US$9.50, representing a drop in value of 1.45 percent.

Canadian analysts were more reserved with their predictions for the marijuana company.

CIBC Capital Markets equity research analyst John Zamparo assigned the company a 12 to 18 month price target of US$11. The analyst highlighted some of the perks for Sundial Growers but, ultimately, issued a “neutral” rating.

“Execution risk exists across the cannabis space but is particularly relevant at Sundial, in our view, as the company has little by way of a performance track record,” Zamparo wrote in his research note.

The analyst expressed reservations about the company’s ability to differentiate its products enough to execute in North America and the UK.

Tamy Chen, equity research analyst with BMO Capital Markets, initiated her coverage with a price target of US$11.

The marijuana company has operating facilities in Canada and the UK. Sundial Growers reached the NASDAQ in August by way of an initial public offering (IPO) of 10 million shares.

The company released its shares at a price of US$13 each. Following the completion of its IPO, Sundial Growers gained gross proceeds of US$143 million. It has been approved for two facilities in Alberta.

According to the company’s Q2 2019 financial report, its purpose-built modular facility in Olds, Alberta, has produced over 150 harvests in 2019, averaging yields of over 50 grams a square foot. The company reported C$20.3 million in revenue for Q2 2019, which Zamparo called impressive in his note.

In August, MarketWatch reported that Sundial Growers was facing the return of half of a wholesale order of marijuana product sold to Zenabis Global (TSX:ZENA). According to unnamed sources, Zenabis said the product from Sundial Growers was of low quality. MarketWatch states:

In its own June-quarter report the same morning, Canadian cannabis company Zenabis Global disclosed that it had returned a half ton of pot and terminated its agreement to buy weed from a “third party” that it did not name. People familiar with the matter say that party was Sundial, and Zenabis returned the cannabis because the pot was of poor quality and contained bits of rubber, among other issues.

Following the report from MarketWatch, the company issued a statement indicating it did not notice any impact on its Q2 earnings or its upcoming Q3 report.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Partnership Aimed at Delivering Psychedelic
Capsule for Dosing Study in Human Clinical Trial

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, and Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, have met another early milestone in the development of an initial all natural psilocybin extract.

Keep reading... Show less

Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, and Numinus Wellness Inc. (“Numinus“) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, have met another early milestone in the development of an initial all natural psilocybin extract.

Optimi and Numinus, through Impact Clinical Trials Accelerator at the University of Calgary (“Impact”), have submitted a pre-clinical trial application to Health Canada for review and comment. Meanwhile, cultivation, research, formulation, and continuous validation studies to produce the investigational psilocybin extract for trial continue at the Health Canada-licensed Numinus lab in British Columbia, Canada.

Keep reading... Show less

Poised for Rapid Growth in Europe’s Largest Medical Cannabis Market

Curaleaf Holdings, Inc. (CSE: CURA OTCQX: CURLF) (“Curaleaf” or the “Company”) a leading international provider of consumer products in cannabis, today announced that wholly owned Curaleaf International subsidiary Adven GmbH (“Adven”) has launched its own range of medical cannabis products in Germany Europe’s largest medical cannabis market.  The initial launch of a high THC oil product aims to meet immediate patient demand and will be extended over the course of the year to incorporate a number of different strengths and THCCBD formulations in both oil and flower formats, addressing a wide range of patient needs. Germany is Europe’s largest medical cannabis market and is expected to be worth US$2.1 billion by 2025 1 .

Keep reading... Show less

After announcing placements of Fit Soda™ in well-known regional grocery chains such as HEB and Sprouts, Koios is pleased to announce that its Fit Soda™ functional beverage is now available in all Food Lion supermarkets, a chain which operates more than 1,100 grocery stores in the eastern United States. As the sugar-free beverage category continues to grow, Coca-Cola recently announced its prediction that its “Coke Zero Sugar” variety will be the firm’s biggest driver of growth in 2021 and beyond. Based on these industry trends, Koios’ objective is to strategically grow the market presence of Fit Soda™, which sold approximately 700,000 units in 2020, its first full calendar year on the market.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that as of Monday, May 10, 2021 all four flavours of Fit Soda ™ are being carried in more than 1,100 supermarkets operated by Food Lion LLC (“Food Lion”), a multistate grocery chain based in Salisbury, North Carolina. Since November 2020, the Company has placed its Fit Soda ™ functional beverage product with several other regional chains across the United States to include HEB (as announced in a November 4, 2020 press release), all three banners of Massachusetts-based Roche Bros. (as announced in a February 24, 2021 press release), and Sprouts Farmers Market (as announced in a March 4, 2021 press release). Approximately 700,000 units of Fit Soda ™ were sold during the product’s first full calendar year of retail sales in 2020 between retail placements in grocery and foodservice outlets, as well as direct-to-consumer sales through the Koios online store. With the addition of Fit Soda ™ to all 1,100 locations of Food Lion across ten U.S. states, the Company believes there is significant opportunity for Fit Soda ™ to have its best year yet in 2021.

Keep reading... Show less

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Harvest Health & Recreation Inc. (OTCQX: HRVSF) to Trulieve Cannabis Corp. is fair to Harvest Health shareholders. Under the terms of the agreement, Harvest shareholders will receive 0.1170 of a subordinate voting share of Trulieve for each Harvest subordinate voting share (or equivalent) held.

Halper Sadeh encourages Harvest Health shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com .

Keep reading... Show less